Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
Back to Search Results

Connection

Search Results to Gregory G Schwartz

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Schwartz, Gregory

Item TypeName
Academic Article The PPAR-alpha activator fenofibrate fails to provide myocardial protection in ischemia and reperfusion in pigs.
Academic Article PPAR-gamma activation fails to provide myocardial protection in ischemia and reperfusion in pigs.
Academic Article PPAR-? as a therapeutic target in cardiovascular disease: evidence and uncertainty.
Concept Peroxisome Proliferator-Activated Receptors
Concept PPAR alpha
Concept PPAR gamma
Academic Article Evaluation of the dual peroxisome proliferator-activated receptor a/? agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial.
Academic Article Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.
Academic Article Effects of the dual peroxisome proliferator-activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes.
Academic Article Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
Academic Article Post-Discharge Worsening Renal Function in Patients with Type 2 Diabetes and Recent Acute?Coronary Syndrome.
Grant Diet-Induced Insulin Resistance and Myocardial Ischemia in Pigs
Grant Diet-Induced Insulin Resistance and Myocardial Ischemia in Pigs
Academic Article Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial.
Academic Article Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-a/? agonist aleglitazar.

Search Criteria
  • Peroxisome Proliferator Activated Receptors

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)